Healthcare provider profile · identity verified

Gerard Ventrella, M.D.

Family Practice · ELMER, NJ · NPI 1639157068

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	116
Levothyroxine Sodium	Levothyroxine Sodium	408	113
Lisinopril	Lisinopril	374	111
Simvastatin	Simvastatin	343	94
Amlodipine Besylate	Amlodipine Besylate	270	84
Metformin Hcl	Metformin Hcl	235	68
Metoprolol Succinate	Metoprolol Succinate	209	59
Alprazolam	Alprazolam	189	34
Hydrochlorothiazide	Hydrochlorothiazide	182	52
Atenolol	Atenolol	159	44
Tramadol Hcl	Tramadol Hcl	153	38
Omeprazole	Omeprazole	152	46
Losartan Potassium	Losartan Potassium	148	43
Glimepiride	Glimepiride	135	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	135	16
Pantoprazole Sodium	Pantoprazole Sodium	135	43
Rosuvastatin Calcium	Rosuvastatin Calcium	124	39
Albuterol Sulfate Hfa	Albuterol Sulfate	116	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	30
Sertraline Hcl	Sertraline Hcl	107	31
Escitalopram Oxalate	Escitalopram Oxalate	102	30
Furosemide	Furosemide	98	31
Methylprednisolone	Methylprednisolone	95	86
Gabapentin	Gabapentin	84	25
Synthroid	Levothyroxine Sodium	82	25
Tamsulosin Hcl	Tamsulosin Hcl	82	23
Trazodone Hcl	Trazodone Hcl	71	25
Eliquis	Apixaban	67	20
Metoprolol Tartrate	Metoprolol Tartrate	65	23
Esomeprazole Magnesium	Esomeprazole Magnesium	64	16
Duloxetine Hcl	Duloxetine Hcl	60	16
Montelukast Sodium	Montelukast Sodium	60	19
Allopurinol	Allopurinol	59	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	suppressed
Clonazepam	Clonazepam	57	11
Carvedilol	Carvedilol	56	17
Venlafaxine Hcl Er	Venlafaxine Hcl	53	13
Pioglitazone Hcl	Pioglitazone Hcl	51	15
Amoxicillin	Amoxicillin	47	40
Azithromycin	Azithromycin	47	43
Clopidogrel	Clopidogrel Bisulfate	45	13
Pravastatin Sodium	Pravastatin Sodium	45	suppressed
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Metformin Hcl Er	Metformin Hcl	42	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	33
Fluoxetine Hcl	Fluoxetine Hcl	41	11
Ozempic	Semaglutide	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	13
Valsartan	Valsartan	40	12
Potassium Chloride	Potassium Chloride	39	15
Farxiga	Dapagliflozin Propanediol	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	11
Famotidine	Famotidine	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	35	11
Ezetimibe	Ezetimibe	33	suppressed
Jardiance	Empagliflozin	33	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Finasteride	Finasteride	31	suppressed
Nebivolol Hcl	Nebivolol Hcl	31	suppressed
Ramipril	Ramipril	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Meloxicam	Meloxicam	30	12
Prednisone	Prednisone	30	19
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Baclofen	Baclofen	27	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	27	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	11
Ibuprofen	Ibuprofen	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	23
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Mometasone Furoate	Mometasone Furoate	23	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Naproxen	Naproxen	21	suppressed
Nystatin	Nystatin	21	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Fluconazole	Fluconazole	20	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Diazepam	Diazepam	17	suppressed
Digoxin	Digoxin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Cefdinir	Cefdinir	15	13
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	11
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Desloratadine	Desloratadine	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	14	14
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Glipizide	Glipizide	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error